Healthcare >> CEO Interviews >> October 1, 2001
Robert M. Di Scipio is Vice President of Corporate Development,
Secretary and General Counsel at OmegaTech, Inc. He earned a JD degree
from Pace University School of Law; BA, University of Michigan In
addition to managing corporate and legal affairs and public relations,
Mr. Di Scipio is also responsible for the company's Asian-Pacific
operations. Mr. Di Scipio has initiated commercial activity in Japan,
China, Australia and established a sales/distribution network throughout
much of the Pacific Rim. Before joining OmegaTech, Mr. Di Scipio was the
Managing Partner of the Connecticut law firm, Hawthorne Ackerly &
Dorrance, where he practiced in the areas of taxation and corporate law.
Previously, Mr. Di Scipio was a Tax Attorney with Coopers & Lybrand.
Mr. Di Scipio is a member of the New York, Connecticut and American Bar
Associations. Profile
Mark A. Braman, is President and CEO of OmegaTech, Inc. Mr. Braman
brings over 20 years of experience in the food, pharmaceutical and
chemical industries to his position of leadership at OmegaTech. Prior
to joining the company, Mr. Braman held multiple positions at Cultor
Food Science, where he was Executive Vice President, President of the
Fine Ingredients Division and Chairman of Cultor China, LTD. From 1984
to 1996 he held a number of positions at Pfizer Inc. Food Science Group.
At the time of Pfizer's divestment of their Food Ingredients business to
Cultor, Mr. Braman held the position of Vice President of Business
Development. Since joining OmegaTech in mid-1997, Mr. Braman has led
OmegaTech in raising over $50 million to drive its business strategies,
including a $22.5 million private placement round completed in May 2000.
Mr. Braman has built the company from seven employees to an
international team of over 70 professionals, orchestrated the national
roll-out of the Gold Circle Farms(r) brand and expanded OmegaTech's
existing bioactive lipid R&D pipeline with state-of-the-art research
facilities in both the US and Germany. He has expanded the company's
ingredients business into all nutritional product areas including
functional foods, infant and early childhood nutrition products,
pharmaceuticals, dietary supplements and animal health products. Profile
Mr. Braman: OmegaTech is a privately-held biotechnology company focused
on the research, development and
